30 Minutes of Aerobic Exercise Weekly Cuts Body Fat in Adults With Overweight or Obesity
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- Among adults with overweight or obesity, 30 minutes of aerobic exercise per week is associated with moderate reductions in body weight, waist circumference, and body fat measures, according to a review published online Dec. 26 in JAMA Network Open.
Ahmad Jayedi, Ph.D., from Imperial College London, and colleagues examined the dose-response association of aerobic exercise with adiposity measures. A total of 116 randomized clinical trials involving 6,880 participants with overweight or obesity were included in the meta-analysis.
The researchers found that each 30 minutes per week of aerobic exercise was associated with reduced body weight (0.52 kg), waist circumference (0.56 cm), body fat percentage (0.37 percent), and the areas of visceral and adipose subcutaneous tissues (mean differences, −1.60 and −1.37 cm2, respectively). Modestly increased physical and mental aspects of quality of life were seen in association with aerobic exercise (standardized mean difference, 1.69 and 0.74 standard deviation, respectively). Modestly increased mild-to-moderate adverse events were seen in association with aerobic exercise and were mostly musculoskeletal symptoms (risk difference, two more events per 100 participants). With increasing duration of aerobic exercise to 300 minutes per week, body weight, waist circumference, and body fat measures decreased linearly or monotonically; clinically important reductions in waist circumference and body fat resulted from aerobic exercise lasting 150 minutes per week at moderate-to-vigorous intensities.
"Our results suggest that aerobic training exceeding 150 minutes per week at moderate intensity or greater may be needed to achieve associations with clinically important reductions," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-31 12:00
Read more

- Susan Monarez Named CDC Director
- Total Injury Death Rate Increased From 2013 to 2021, Followed by Decline
- FDA Approves Arbli (losartan potassium) Oral Suspension as the First Ready-to-Use Oral Liquid Losartan in the U.S.
- Increase in Internalizing Behaviors in Teens Observed Over Last 30 Years
- 2009 to 2019 Saw Increase in Avoidable Mortality in United States
- Local Outbreaks Can Motivate The Vaccine-Hesitant, Poll Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions